These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12416491)

  • 21. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differential therapy of hypertension becomes more specific. Interview by Dr. R.-G. Sommer].
    Unger T
    Fortschr Med; 1997 Aug; 115(24):42-3. PubMed ID: 9410822
    [No Abstract]   [Full Text] [Related]  

  • 23. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT?
    Swedberg K; McMurray JJ
    Eur Heart J; 2004 Mar; 25(5):357-8. PubMed ID: 15033244
    [No Abstract]   [Full Text] [Related]  

  • 25. Valsartan in chronic heart failure.
    Ripley TL
    Ann Pharmacother; 2005 Mar; 39(3):460-9. PubMed ID: 15687480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
    Roger N; Popovic I; Madelenat P; Mahieu-Caputo D
    Gynecol Obstet Fertil; 2007 Jun; 35(6):556-60. PubMed ID: 17544313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial).
    Majahalme SK; Baruch L; Aknay N; Goedel-Meinen L; Hofmann M; Hester A; Prescott MF; Feliciano N;
    Am J Cardiol; 2005 Feb; 95(4):529-32. PubMed ID: 15695147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valsartan, captopril, or both in myocardial infarction.
    Moshenyat R; Kupfer Y; Tessler S
    N Engl J Med; 2004 Feb; 350(9):943-5; author reply 943-5. PubMed ID: 14988935
    [No Abstract]   [Full Text] [Related]  

  • 29. Valsartan, captopril, or both in myocardial infarction.
    Jorde UP
    N Engl J Med; 2004 Feb; 350(9):943-5; author reply 943-5. PubMed ID: 14988936
    [No Abstract]   [Full Text] [Related]  

  • 30. [Convincing results from the JIKEI Study].
    MMW Fortschr Med; 2006 Dec; 148(51-52):55. PubMed ID: 17619349
    [No Abstract]   [Full Text] [Related]  

  • 31. Lessons learned from the valsartan- heart failure trial (Val-HeFT): angiotensin receptor blockers in heart failure.
    Cohn JN
    Am J Cardiol; 2002 Nov; 90(9):992-3. PubMed ID: 12398968
    [No Abstract]   [Full Text] [Related]  

  • 32. [Successful mega studies with heart patients. Valsartan possesses cardioprotective action].
    MMW Fortschr Med; 2006 Feb; 148(5):48-9. PubMed ID: 16518941
    [No Abstract]   [Full Text] [Related]  

  • 33. [Value in heart failure proven again. AT II blocker soon also for post-infarct patients?].
    MMW Fortschr Med; 2003 Oct; 145(43):51. PubMed ID: 14664222
    [No Abstract]   [Full Text] [Related]  

  • 34. Angiotensin receptor blockers and myocardial infarction: the importance of dosage.
    Sarzani R; Dessì-Fulgheri P
    J Hypertens; 2006 Aug; 24(8):1679-81; author reply 1681-2. PubMed ID: 16877973
    [No Abstract]   [Full Text] [Related]  

  • 35. [New combination of high dosage sartan and 25 mg HCT. Systolic blood pressure lowered by 21 mmHg].
    MMW Fortschr Med; 2004 Apr; 146(15):68. PubMed ID: 15373029
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sartans for lowering blood pressure. Hypertensive patients need not fear potency].
    MMW Fortschr Med; 2002 Apr; 144(17):48. PubMed ID: 12048853
    [No Abstract]   [Full Text] [Related]  

  • 37. [Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)].
    Scholze J; Müller U
    MMW Fortschr Med; 2006 Oct; 148(42):48. PubMed ID: 17621800
    [No Abstract]   [Full Text] [Related]  

  • 38. [First fixed combination of sartan and high-dosage diuretic. A strong duo against high blood pressure].
    MMW Fortschr Med; 2004 Apr; 146(14):45. PubMed ID: 15344757
    [No Abstract]   [Full Text] [Related]  

  • 39. [Valsartan improves symptoms and quality of life in patients with chronic heart failure].
    Baumhäkel M; Müller U; Böhm M
    MMW Fortschr Med; 2008 Apr; 150 Suppl 1():48-53. PubMed ID: 18540333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT?
    McMurray JJ
    J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):89-92. PubMed ID: 11881104
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.